<DOC>
	<DOCNO>NCT03075995</DOCNO>
	<brief_summary>Food make big difference bioavailability lapatinib breast cancer patient , fatty food increase lapatinib bioavailability.By examine steady blood drug concentration individual different treatment mode lapatinib , emptiness take fatty food , discus best mode take lapatinib fatty food .</brief_summary>
	<brief_title>To Discuss Best Mode Taking Lapatinib Under Influence Diet</brief_title>
	<detailed_description>Metastatic breast cancer lead cause cancer-related death among woman worldwide , overexpress HER2 associate high risk . Lapatinib approve use treat advance metastatic breast cancer . The pharmacokinetic parameter lapatinib characterize previously.It reach steady state concentration 6 7 day oral dosing , bioavailability different different patient . The effect food lapatinib pharmacokinetics human first examine 19 healthy participant give single 100-mg dos high-fat breakfast . Food cause 60 % increase relative bioavailability lapatinib.Another test show bioavailability lapatinib 3 time low-fat diet emptiness . Some investigator think change mode take lapatinib food without food enhance absorption.It may decrease oral dose lapatinib reach steady state concentration , achieve maximum economic benefit . By continuous change lapatinib fat diet , The change lapatinib pharmacokinetic lack discussion . If adverse reaction increase since absorption lapatinib increase , exist research data still lack . The trial By examine steady blood drug concentration individual different treatment mode lapatinib , emptiness take fatty food , discus best mode take lapatinib fatty food .</detailed_description>
	<mesh_term>Lapatinib</mesh_term>
	<criteria>1 . Advance breast cancer her2 positive 2 . The patient ready use use lapatinib tumor treatment , plan keep treatment least month 3 . The ECOG score 0 2 4. hemoglobin≥ 9 gm/dL 5. serum albumin concentration normal 6 . ALT / AST / bilirubin &lt; 1.5UL 7. creatinine clearance rate≥ 40 mL/min 8. sign ICF 1 . Pregnancy Pregnancy 2 . Stomach absorption dysfunction 3 . Difficulty take fatty food 4 . Severe heart disease medical condition</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>lapatinib</keyword>
	<keyword>steady state plasma concentration</keyword>
	<keyword>high-fat breakfast</keyword>
</DOC>